KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Current Taxes (2016 - 2017)

Thermo Fisher Scientific's Current Taxes history spans 7 years, with the latest figure at $125.7 million for Q3 2017.

  • For the quarter ending Q3 2017, Current Taxes rose 430.38% year-over-year to $125.7 million, compared with a TTM value of $125.7 million through Sep 2017, up 430.38%, and an annual FY2016 reading of $165.4 million, down 22.16% over the prior year.
  • Current Taxes for Q3 2017 was $125.7 million at Thermo Fisher Scientific, up from $89.9 million in the prior quarter.
  • The five-year high for Current Taxes was $401.9 million in Q1 2014, with the low at $21.8 million in Q3 2016.
  • Average Current Taxes over 4 years is $139.5 million, with a median of $89.9 million recorded in 2017.
  • Year-over-year, Current Taxes crashed 90.27% in 2015 and then soared 430.38% in 2017.
  • Tracing TMO's Current Taxes over 4 years: stood at $165.1 million in 2014, then rose by 28.71% to $212.5 million in 2015, then decreased by 22.16% to $165.4 million in 2016, then dropped by 24.0% to $125.7 million in 2017.
  • Per Business Quant, the three most recent readings for TMO's Current Taxes are $125.7 million (Q3 2017), $89.9 million (Q3 2017), and $82.2 million (Q2 2017).